Published in J Comp Neurol on February 11, 2002
Soluble neuregulin-1 has bifunctional, concentration-dependent effects on Schwann cell myelination. J Neurosci (2010) 1.23
Identified olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J Neurosci (2004) 1.09
Spider silk constructs enhance axonal regeneration and remyelination in long nerve defects in sheep. PLoS One (2011) 1.00
Integration of engrafted Schwann cells into injured peripheral nerve: axonal association and nodal formation on regenerated axons. Neurosci Lett (2005) 0.99
Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury. Neurosci Lett (2009) 0.89
Soluble Neuregulin and Schwann Cell Myelination: a Therapeutic Potential for Improving Remyelination of Adult Axons. Mol Cell Pharmacol (2010) 0.87
Multiple sclerosis: can Schwann cells wrap it up? Yale J Biol Med (2002) 0.77
Salidroside promotes peripheral nerve regeneration based on tissue engineering strategy using Schwann cells and PLGA: in vitro and in vivo. Sci Rep (2017) 0.76
Cell transplantation therapy for spinal cord injury. Nat Neurosci (2017) 0.75
Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells. Neurochem Res (2017) 0.75
Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol (1980) 11.52
Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res (1979) 4.39
Evidence that sensory axons are mitogenic for Schwann cells. Nature (1975) 2.35
Myelin-specific proteins and glycolipids in rat Schwann cells and oligodendrocytes in culture. J Cell Biol (1980) 1.98
Remyelination in multiple sclerosis. Ann Neurol (1979) 1.89
Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain (2000) 1.85
Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nat Biotechnol (2000) 1.76
Multiple sclerosis: remyelination of nascent lesions. Ann Neurol (1993) 1.64
Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci (1998) 1.60
ABERRANT NERVE FIBRES WITHIN THE SPINAL CORD. J Neurol Neurosurg Psychiatry (1963) 1.60
Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J Neurosci (1996) 1.59
Schwann cells and peripheral myelin within human central nervous tissues: the mesenchymal character of Schwann cells. J Neuropathol Exp Neurol (1971) 1.53
Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience (1983) 1.48
Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature (1977) 1.46
The use of cultured autologous Schwann cells to remyelinate areas of persistent demyelination in the central nervous system. J Neurol Sci (1985) 1.46
Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia (1999) 1.37
Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia (2000) 1.34
Transplantation of oligodendrocytes and Schwann cells into the spinal cord of the myelin-deficient rat. J Neurocytol (1988) 1.24
Remyelination in multiple sclerosis with peripheral type myelin. Arch Neurol (1973) 1.22
Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons. Neuroscience (1986) 1.21
Central axons in injured cat spinal cord recover electrophysiological function following remyelination by Schwann cells. J Neurol Sci (1989) 1.21
Conduction properties of central nerve fibers remyelinated by Schwann cells. Brain Res (1992) 1.17
Suppression of remyelination in the CNS by X-irradiation. Acta Neuropathol (1978) 1.16
Transplantation of rat Schwann cells grown in tissue culture into the mouse spinal cord. J Neurol Sci (1981) 1.08
Requirements for Schwann cell migration within CNS environments: a viewpoint. Int J Dev Neurosci (1993) 1.07
Transplantation of human embryonic oligodendrocytes into shiverer brain. Ann N Y Acad Sci (1987) 1.04
Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions. Ann Neurol (1983) 1.03
Repair of a myelin lesion by Schwann cells transplanted in the adult mouse spinal cord. J Neuroimmunol (1992) 1.01
Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system. Neurology (1966) 0.97
Transplantation options for therapeutic central nervous system remyelination. Cell Transplant (2000) 0.97
Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP). Acta Neuropathol (1985) 0.96
Regeneration in the adult central nervous system: experimental repair strategies. Nat Med (1997) 0.96
Nerve fibres in spinal cord impact injuries. Part 1. Changes in the myelin sheath during the initial 5 weeks. J Neurol Sci (1983) 0.95
The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord. J Neurocytol (1989) 0.93
Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J Neurocytol (1987) 0.93
Survival and differentiation of oligodendrocytes from neural tissue transplanted into new-born mouse brain. Neurosci Lett (1983) 0.92
Schwann cells transplanted into normal and X-irradiated adult white matter do not migrate extensively and show poor long-term survival. Exp Neurol (2000) 0.91
Fibroblasts are required for Schwann cell basal lamina deposition and ensheathment of unmyelinated sympathetic neurites in culture. J Neurocytol (1993) 0.91
Type 1 astrocytes fail to inhibit Schwann cell remyelination of CNS axons in the absence of cells of the O-2A lineage. Dev Neurosci (1992) 0.91
Remyelination after transient experimental compression of the spinal cord. Ann Neurol (1977) 0.91
Schwann cells and regenerated peripheral myelin in multiple sclerosis: an ultrastructural study. Neurology (1975) 0.89
Lesion-induced myelin formation in the retina. J Neurocytol (1985) 0.85
Schwann cell remyelination is restricted to astrocyte-deficient areas after transplantation into demyelinated adult rat brain. J Neurosci Res (2000) 0.85
Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J Neuroimmunol (1992) 0.85
Glial cell transplants: experimental therapies of myelin diseases. Brain Pathol (1995) 0.84
Pathways of migration of transplanted Schwann cells in the demyelinated mouse spinal cord. J Neurosci Res (1993) 0.83
Schwann cells divide in a demyelinating lesion of the central nervous system. Brain Res (1987) 0.82
Astrocyte-Schwann cell interactions in culture. Glia (1994) 0.82
Integration of transplanted cultured Schwann cells into the long myelinated fiber tracts of the adult spinal cord. Exp Neurol (1997) 0.82
Schwann cell transplantation and myelin repair of the CNS. Mult Scler (1997) 0.82
Morphology and migration of cultured Schwann cells transplanted into the fimbria and hippocampus in adult rats. Glia (1993) 0.81
Schwann cells transplanted into the CNS. Int J Dev Neurosci (1993) 0.81
Extrusion transplantation of Schwann cells into the adult rat thalamus induces directional host axon growth. Exp Neurol (1994) 0.79
Death of oligodendrocytes and microglial phagocytosis of myelin precede immigration of Schwann cells into the spinal cord. J Neurocytol (2000) 0.79
The astrocyte inhibition of peripheral nerve regeneration is reversed by Schwann cells. Exp Neurol (1994) 0.79
Rat Schwann cell remyelination of demyelinated cat CNS axons: evidence that injection of cell suspensions of CNS tissue results in Schwann cell remyelination. Neurosci Lett (1987) 0.78
The reconstruction of an astrocytic environment in glia-deficient areas of white matter. J Neurocytol (1993) 0.78
Nodal spacing along regenerated axons following a crush lesion of the developing rat sciatic nerve. Brain Res (1987) 0.77
Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS. Glia (1995) 0.77
Functional properties and nodal spacing of myelinated fibers in developing rat mental and sural nerves. Brain Res Dev Brain Res (1994) 0.76
Astrocytes inhibit Schwann cell proliferation and myelination of dorsal root ganglion neurons in vitro. J Neurosci (1994) 0.76
A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res (2004) 2.11
Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther (2005) 1.91
BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther (2004) 1.87
Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci (2002) 1.75
Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain (2011) 1.73
Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia (2002) 1.68
Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci (2005) 1.68
BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci (2009) 1.40
Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke (2010) 1.39
Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma (2007) 1.33
Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp Hematol (2003) 1.29
Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res (2006) 1.27
Intravenous administration of mesenchymal stem cells derived from bone marrow after contusive spinal cord injury improves functional outcome. Brain Res (2010) 1.22
Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab (2007) 1.21
Identified olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J Neurosci (2004) 1.09
Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med (2012) 1.08
Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res (2008) 1.08
Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol (2008) 1.08
Protection of corticospinal tract neurons after dorsal spinal cord transection and engraftment of olfactory ensheathing cells. Glia (2006) 1.07
Oscillatory mechanism in primary sensory neurones. Brain (2002) 1.06
Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. J Neurosci (2005) 1.06
Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res (2010) 1.05
Transplantation of olfactory ensheathing cells enhances peripheral nerve regeneration after microsurgical nerve repair. Brain Res (2008) 1.00
Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res (2009) 0.99
Integration of engrafted Schwann cells into injured peripheral nerve: axonal association and nodal formation on regenerated axons. Neurosci Lett (2005) 0.99
Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. J Neurosci (2006) 0.98
Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain. Pain (2009) 0.97
Subthreshold oscillations induced by spinal nerve injury in dissociated muscle and cutaneous afferents of mouse DRG. J Neurophysiol (2002) 0.97
Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells. Brain Res (2006) 0.96
Mesenchymal stem cells transmigrate across brain microvascular endothelial cell monolayers through transiently formed inter-endothelial gaps. Neurosci Lett (2011) 0.95
Olfactory ensheathing cells exhibit unique migratory, phagocytic, and myelinating properties in the X-irradiated spinal cord not shared by Schwann cells. Glia (2008) 0.94
Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PLoS One (2011) 0.93
Remyelination of spinal cord axons by olfactory ensheathing cells and Schwann cells derived from a transgenic rat expressing alkaline phosphatase marker gene. Neuron Glia Biol (2004) 0.92
Prediction of prolonged postprocedural hypotension after carotid artery stenting. Neurosurgery (2005) 0.90
Bone marrow stem cells in experimental stroke. Prog Brain Res (2012) 0.90
Myelination and nodal formation of regenerated peripheral nerve fibers following transplantation of acutely prepared olfactory ensheathing cells. Brain Res (2006) 0.90
Autologous transplantation of expanded neural precursor cells into the demyelinated monkey spinal cord. Brain Res (2004) 0.89
A rat middle cerebral artery occlusion model and intravenous cellular delivery. Methods Mol Biol (2009) 0.88
Remyelination of the injured spinal cord. Prog Brain Res (2007) 0.87
Expression of aquaporin-4 augments cytotoxic brain edema after traumatic brain injury during acute ethanol exposure. Am J Pathol (2011) 0.87
[Chiari malformation (type 1) with regeneration of removed C1 lamina after foramen magnum decompression: a case report]. No Shinkei Geka (2005) 0.86
Remyelination after olfactory ensheathing cell transplantation into diverse demyelinating environments. Exp Neurol (2011) 0.86
Impaired spinal cord remyelination by long-term cultured adult porcine olfactory ensheathing cells correlates with altered in vitro phenotypic properties. Xenotransplantation (2010) 0.85
[Analysis of dot-like hemosiderin spots using brain dock system]. No Shinkei Geka (2003) 0.85
Remyelination of the nonhuman primate spinal cord by transplantation of H-transferase transgenic adult pig olfactory ensheathing cells. FASEB J (2003) 0.85
Identification of chemoattractive factors involved in the migration of bone marrow-derived mesenchymal stem cells to brain lesions caused by prions. J Virol (2011) 0.85
CNPase expression in olfactory ensheathing cells. J Biomed Biotechnol (2011) 0.84
Magnetic resonance lactate and lipid signals in rat brain after middle cerebral artery occlusion model. Brain Res (2006) 0.84
Noninactivating, tetrodotoxin-sensitive Na+ conductance in peripheral axons. Muscle Nerve (2003) 0.83
Effect of transplantation of bone marrow-derived mesenchymal stem cells on mice infected with prions. J Virol (2009) 0.83
Prior ethanol injection promotes brain edema after traumatic brain injury. J Neurotrauma (2009) 0.81
Local anesthetic effects of cocaethylene and isopropylcocaine on rat peripheral nerves. Brain Res (2004) 0.81
Bilateral cortical hyperactivity detected by fMRI associates with improved motor function following intravenous infusion of mesenchymal stem cells in a rat stroke model. Brain Res (2012) 0.81
A-fiber sprouting in spinal cord dorsal horn is attenuated by proximal nerve stump encapsulation. Exp Neurol (2002) 0.80
Postoperative rupture of an untreated aneurysm on the 3rd day after subarachnoid hemorrhage surgery. Neurol Med Chir (Tokyo) (2005) 0.80
Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice. J Neurosci Res (2012) 0.78
Olfactory ensheathing cells, but not Schwann cells, proliferate and migrate extensively within moderately X-irradiated juvenile rat brain. Glia (2013) 0.78
Schwann cell engraftment into injured peripheral nerve prevents changes in action potential properties. J Neurophysiol (2005) 0.78
Potential of olfactory ensheathing cells for cell-based therapy in spinal cord injury. J Rehabil Res Dev (2008) 0.78
Olfactory-ensheathing cell transplantation for peripheral nerve repair: update on recent developments. Cells Tissues Organs (2015) 0.78
Subarachnoid hemosiderin deposition after subarachnoid hemorrhage on T2*-weighted MRI correlates with the location of disturbed cerebrospinal fluid flow on computed tomography cisternography. Neurol India (2008) 0.77
[A case of a ruptured pseudoaneurysm arising from the distal part of the posterior inferior cerebellar artery]. No Shinkei Geka (2002) 0.77
Chapter 22: Transplantation of olfactory ensheathing cells for peripheral nerve regeneration. Int Rev Neurobiol (2009) 0.77
Peripheral nerve injuries and transplantation of olfactory ensheathing cells for axonal regeneration and remyelination: fact or fiction? Int J Mol Sci (2012) 0.76
Paracrine loop of keratinocyte proliferation and directed neuritic outgrowth in a neuroepithelial coculture. Ann Plast Surg (2013) 0.76
Intravenous mesenchymal stem cell therapy after recurrent laryngeal nerve injury: a preliminary study. Laryngoscope (2014) 0.76
Convergence of cells from the progenitor fraction of adult olfactory bulb tissue to remyelinating glia in demyelinating spinal cord lesions. PLoS One (2009) 0.76
Optimization of three-dimensional time-of-flight magnetic resonance angiography of the intracranial arteries. Neurol Med Chir (Tokyo) (2006) 0.76
Neuroprotection and immunomodulation by cell transplantation are becoming central themes in potential therapeutic approaches for cell-based therapies. Neurosci Lett (2009) 0.75
T2 reversed fast spin-echo image and enhanced three-dimensional surface MR angiography for the diagnosis of cerebral arteriovenous malformations. J Clin Neurosci (2002) 0.75
[Preemptive analgesia for postoperative pain after frontotemporal craniotomy]. No Shinkei Geka (2002) 0.75
[Multiple intracerebral microhemorrhages associated with primary aldosteronism: a case report]. No Shinkei Geka (2003) 0.75
[Phase III clinical trial using autologous mesenchymal stem cells for stroke patients]. Nihon Rinsho (2016) 0.75
[Dynamic changes in magnetic resonance diffusion-weighted and fluid-attenuated images of cerebral fat embolism: a case report]. No To Shinkei (2002) 0.75
[Bone marrow stem cell therapy for stroke]. Nihon Rinsho (2011) 0.75
Spinal cord infarct as the initial clinical presentation of intravascular malignant lymphomatosis. J Clin Neurosci (2009) 0.75
[111In-DTPA cisterno SPECT for the diagnosis of CSF rhinorrhea: case report]. No Shinkei Geka (2002) 0.75
[Treatment of cerebral ischemia using mesenchymal stem cell-clinical trial phase III]. Nihon Jibiinkoka Gakkai Kaiho (2015) 0.75